Matinas BioPharma Holdings Inc (MTNB) — Net Asset Quality Index
Matinas BioPharma Holdings Inc (MTNB) has a Net Asset Quality Index of 51.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $5.87 Million minus total liabilities of $2.85 Million yields net assets of $3.02 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Matinas BioPharma Holdings Inc debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Matinas BioPharma Holdings Inc Net Asset Quality Index Over Time (2012–2025)
This chart shows how Matinas BioPharma Holdings Inc's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 51.4%, representing net assets of $3.02 Million against total assets of $5.87 Million USD. For live market cap and overall valuation, see Matinas BioPharma Holdings Inc market capitalisation.
Annual Net Asset Quality Index for Matinas BioPharma Holdings Inc (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Matinas BioPharma Holdings Inc from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Matinas BioPharma Holdings Inc (MTNB) strategic investment index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.0% | $4.83 Million | $7.21 Million | $2.38 Million | ▲ +7.0 pp |
| 2024 | 60.0% | $7.59 Million | $12.64 Million | $5.05 Million | ▼ -16.6 pp |
| 2023 | 76.7% | $19.25 Million | $25.10 Million | $5.86 Million | ▲ +30.2 pp |
| 2022 | 46.5% | $36.64 Million | $78.87 Million | $42.23 Million | ▼ -39.1 pp |
| 2021 | 85.6% | $52.49 Million | $61.33 Million | $8.83 Million | ▼ -4.2 pp |
| 2020 | 89.8% | $63.73 Million | $70.97 Million | $7.24 Million | ▲ +7.7 pp |
| 2019 | 82.1% | $33.05 Million | $40.24 Million | $7.19 Million | ▲ +1.2 pp |
| 2018 | 80.9% | $16.14 Million | $19.94 Million | $3.80 Million | ▲ +6.9 pp |
| 2017 | 74.1% | $10.68 Million | $14.42 Million | $3.74 Million | ▲ +1.2 pp |
| 2016 | 72.8% | $7.15 Million | $9.82 Million | $2.67 Million | ▲ +0.6 pp |
| 2015 | 72.2% | $6.07 Million | $8.41 Million | $2.33 Million | ▲ +6.0 pp |
| 2014 | 66.3% | $2.23 Million | $3.36 Million | $1.13 Million | ▼ -26.1 pp |
| 2013 | 92.4% | $10.47 Million | $11.33 Million | $858.97K | ▲ +12.3 pp |
| 2012 | 80.1% | $339.94K | $424.36K | $84.43K | — |